Fulgent Genetics, Inc.FLGTNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank18
3Y CAGR+19.4%
5Y CAGR-2.2%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+19.4%/yr
vs -12.4%/yr prior
5Y CAGR
-2.2%/yr
Recent acceleration
Acceleration
+31.8pp
Accelerating
Percentile
P18
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20252.35+30.3%
20241.81-33.0%
20232.69+94.8%
20221.38-51.2%
20212.84+7.7%
20202.63-63.1%
20197.13+203.2%
20182.35-38.1%
20173.80-64.7%
201610.76-